Drug Topics

JANUARY 5, 2023

List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.

530

530

PharmaVoice

JANUARY 3, 2023

Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis.

279

279

PhRMA

JANUARY 5, 2023

New research published in the American Journal of Managed Care (AJMC) underscores the critical role that medicines play in improving health and reducing disease complications and other, often costly, medical care and services. The study finds that since curative direct-acting antiviral medications for hepatitis C were approved in 2013, even after factoring in the cost of treatment, Medicaid has saved an estimated $15 billion in avoided health care costs and nearly 285,000 Medicaid enrollees are

276

276

Pharmacy Times

JANUARY 3, 2023

In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.

Communication 171

Communication 171

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 6, 2023

A local West Virginia mechanic exemplifies the kind of problem-solving that pharmacy executives from major chains should apply to their stores.

503

503

PharmaVoice

JANUARY 4, 2023

How charitable firms such as Advancium are helping to right the market wrongs of drug development.

256

256

Pharmacy Times

JANUARY 4, 2023

The FDA granted fidanacogene elaparvovec breakthrough, regenerative medicines advance therapy, and orphan drug designations.

FDA 152

FDA 152

Drug Topics

JANUARY 5, 2023

Patients with psoriasis seem to suffer more in the wintertime when flare-ups are much more common.

503

503

PharmaVoice

JANUARY 5, 2023

As controversies abound and new drugs rise on the regulatory horizon, this year will be big for Alzheimer’s.

246

246

STAT

JANUARY 3, 2023

A diverse and inclusive workforce benefits science and research. But unless it includes people living with a disability — the largest minority group in the U.S. and around the world — research will never be fully representative and science will not reach its full potential. Although 27% of U.S. adults live with a disability, only 10% of science, engineering, and health doctorate holders, and less than 2% of researchers funded by the National Institutes of Health, report having a di

140

140

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JANUARY 2, 2023

Pharmacists should educate patients about managing respiratory syncytial virus and let them know they may soon be able to get vaccinated.

Vaccines 149

Vaccines 149

Drug Topics

JANUARY 4, 2023

The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.

503

503

PharmaVoice

JANUARY 5, 2023

Why Evernow CEO Alicia Jackson thinks menopause is the perfect inroad to helping women live longer lives.

246

246

Fierce Healthcare

JANUARY 5, 2023

How mental health made the 'remarkable transition' to virtual: study. fdiamond. Thu, 01/05/2023 - 15:21.

139

139

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 3, 2023

Study finds a strong decline in hepatitis C incidence in the years immediately following broad access to direct-acting antiviral drugs.

149

149

Drug Topics

JANUARY 3, 2023

The CDC has reported an increase in drug overdose deaths from 2019 to 2022 in adolescents aged 10 to 19 years.

503

503

PharmaVoice

JANUARY 3, 2023

A preview of the top trends on the minds of industry and market leaders for the new year.

239

239

pharmaphorum

JANUARY 6, 2023

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients. The tool is an example of a large language model or LLM, which are designed to understand queries and generate text responses in plain language, drawing from large and complex datasets – in this case, medical research.

137

137

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 6, 2023

Lecanemab (Lequembi) approved to treat mild cognitive impairment or mild dementia associated with Alzheimer disease.

FDA 139

FDA 139

Drug Topics

JANUARY 3, 2023

Keep your pharmacy services up to date with the latest 2023 ACIP vaccination schedule updates and recommendations.

Vaccines 502

Vaccines 502

Fierce Healthcare

JANUARY 6, 2023

How FTC's noncompete agreements rule could impact healthcare. fdiamond. Fri, 01/06/2023 - 15:55.

134

134

PharmaVoice

JANUARY 6, 2023

Leaders in the space reveal the topics that are top of mind as the year’s biggest healthcare conference kicks off next week.

130

130

Pharmacy Times

JANUARY 6, 2023

Results show an association between linoleic acid, found in nuts, seeds, and vegetable oils, and increased hypersensitivity in psoriatic lesions.

139

139

Drug Topics

JANUARY 4, 2023

Reports of localized supply issues with Tamiflu have left some providers wondering how to best prioritize who gets the antiviral during a rough flu season.

469

469

Fierce Healthcare

JANUARY 6, 2023

Carbon Health announces another round of layoffs, corporate restructuring amid challenging market conditions. hlandi. Fri, 01/06/2023 - 20:01.

129

129

PharmaVoice

JANUARY 4, 2023

The CFO and COO is advancing moonshot efforts to address aging-related diseases for the "healthspan" company and is helping emerging biotechs bring innovations out of academia.

130

130

Pharmacy Times

JANUARY 5, 2023

A panel of medical experts discuss supportive care needs for patients with myelodysplastic syndrome.

139

139

Drug Topics

JANUARY 5, 2023

Following certification, brick-and-mortar pharmacies will be able to provide the medication to patients.

FDA 468

FDA 468

Fierce Healthcare

JANUARY 5, 2023

Commonwealth Fund: Medicare inpatient spending concentrated among 2 systems in most regions. rking. Thu, 01/05/2023 - 15:07.

129

129

STAT

JANUARY 5, 2023

SAN DIEGO — Fate Therapeutics, a biotech upstart with big ambitions to use cell-based therapies to treat autoimmune diseases and cancer, is now planning to cut back on both jobs and experimental drugs after an early end to a deal with Janssen. The setback, announced Thursday, will cut the company’s size to 220 workers by the end of the first quarter of this year.

Immunization 126

Immunization 126

Pharmacy Times

JANUARY 5, 2023

The overall trend of declining body mass index was associated with a higher risk of developing dementia.

139

139

Drug Topics

JANUARY 4, 2023

Research on last season’s influenza vaccine efficacy bodes well for patients who have gotten their flu shot this season.

Vaccines 468

Vaccines 468

Fierce Healthcare

JANUARY 5, 2023

Northern Light Health inks strategic collaboration with Optum. pminemyer. Thu, 01/05/2023 - 15:55.

125

125